Literature DB >> 11117551

Reactivation of human neurotropic JC virus expressing oncogenic protein in a recurrent glioblastoma multiforme.

L Del Valle1, S A Azizi, B Krynska, S Enam, S E Croul, K Khalili.   

Abstract

Examination of the primary tumor of glioblastoma multiforme and its recurrence for their association with JC virus revealed that, while the viral genome is present in both initial and recurrent tumors, expression of the viral oncoprotein T-antigen occurs only in the recurrent tumor cells. Accordingly, the level of inducible cellular transcription factors, including the p65 subunit of NF-kappaB and YB-1, which have the ability to stimulate JCV gene expression, was found to be higher in the recurrent tumor cells. These observations suggest that induction of the regulatory factors after resection of the primary tumor may have reactivated JC virus gene expression and led to redevelopment of the tumor in brain.

Entities:  

Mesh:

Year:  2000        PMID: 11117551

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

Review 1.  Brain tumors and polyomaviruses.

Authors:  Sidney Croul; Jessica Otte; Kamel Khalili
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

Review 2.  Infection, inflammation, and gastrointestinal cancer.

Authors:  C R Boland; M G Luciani; C Gasche; A Goel
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

3.  JC virus-induced Progressive Multifocal Leukoencephalopathy.

Authors:  A Sami Saribas; Ahmet Ozdemir; Cathy Lam; Mahmut Safak
Journal:  Future Virol       Date:  2010-05       Impact factor: 1.831

4.  An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment.

Authors:  Y Kostova; K Mantwill; P S Holm; M Anton
Journal:  Cancer Gene Ther       Date:  2014-12-12       Impact factor: 5.987

Review 5.  Chronic viral infection and primary central nervous system malignancy.

Authors:  Robert Saddawi-Konefka; John R Crawford
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

Review 6.  JC virus: an oncogenic virus in animals and humans?

Authors:  Melissa S Maginnis; Walter J Atwood
Journal:  Semin Cancer Biol       Date:  2009-02-24       Impact factor: 15.707

7.  JC polyomavirus in the aetiology and pathophysiology of glial tumours.

Authors:  Tihomir Eftimov; Yavor Enchev; Iliya Tsekov; Plamen Simeonov; Zlatko Kalvatchev; Elitsa Encheva
Journal:  Neurosurg Rev       Date:  2015-11-12       Impact factor: 3.042

8.  YB-1 and CTCF differentially regulate the 5-HTT polymorphic intron 2 enhancer which predisposes to a variety of neurological disorders.

Authors:  Elena Klenova; Alison C Scott; Julian Roberts; Shaharum Shamsuddin; Elizabeth A Lovejoy; Stephan Bergmann; Vivien J Bubb; Hans-Dieter Royer; John P Quinn
Journal:  J Neurosci       Date:  2004-06-30       Impact factor: 6.167

Review 9.  Review on the role of the human Polyomavirus JC in the development of tumors.

Authors:  Serena Delbue; Manola Comar; Pasquale Ferrante
Journal:  Infect Agent Cancer       Date:  2017-02-03       Impact factor: 2.965

10.  Evaluation of JC and Cytomegalo Viruses in Glioblastoma Tissue

Authors:  Reza Malekpour Afshar; Hamid Reza Mollaei; Bahare Zandi; Maryam Iranpour
Journal:  Asian Pac J Cancer Prev       Date:  2016-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.